# Silexion Therapeutics Corp — Form D

Silexion Therapeutics Corp of RAMAT GAN, L3, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-11. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-11
- Form: D
- Accession: 0001178913-25-002710
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.6M
- Amount sold: $3.6M
- Investors: 11
- Date of first sale: 2025-08-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-554233

## Issuer

- Name: Silexion Therapeutics Corp
- CIK: 0002022416
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: 12 ABBA HILLEL ROAD, RAMAT GAN, L3, 5250606
- Phone: +972-3-756-4999

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Dror Abramov | Director | Ramat Gan, L3 |
| Ruth Alon | Director | Ramat Gan, L3 |
| Ilan Hadar | Director | Ramat Gan, L3 |
| Ilan Levin | Director | Ramat Gan, L3 |
| Avner Lushi | Director | Ramat Gan, L3 |
| Shlomo Noy | Director | Ramat Gan, L3 |
| Amnon Peled | Director | Ramat Gan, L3 |
| Ilan Hadar | Executive Officer | Ramat Gan, L3 |
| Mirit Horenshtein-Hadar | Executive Officer | Ramat Gan, L3 |
| Mitchell Shirvan | Executive Officer | Ramat Gan, L3 |

## More

- [CIK 2022416 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022416&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001178913-25-002710.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.